Xiaoyang Lai

3.0k total citations
27 papers, 551 citations indexed

About

Xiaoyang Lai is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Xiaoyang Lai has authored 27 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in Xiaoyang Lai's work include Liver Disease Diagnosis and Treatment (6 papers), Diabetes and associated disorders (6 papers) and Diabetes Management and Research (4 papers). Xiaoyang Lai is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Diabetes and associated disorders (6 papers) and Diabetes Management and Research (4 papers). Xiaoyang Lai collaborates with scholars based in China and United States. Xiaoyang Lai's co-authors include Yunfeng Shen, Rui Xuan, Jianping Liu, Jianyong Ma, Fuzhou Hua, Fangfang Li, Wengen Zhu, Xingming Shi, Xiao Liu and Jing Zhang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Physiology-Endocrinology and Metabolism and Journal of Cellular Physiology.

In The Last Decade

Xiaoyang Lai

27 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyang Lai China 13 289 127 89 84 84 27 551
Weixia Jian China 16 284 1.0× 191 1.5× 85 1.0× 140 1.7× 63 0.8× 36 742
Can Wu China 13 333 1.2× 121 1.0× 89 1.0× 65 0.8× 195 2.3× 15 710
Lechu Yu China 15 388 1.3× 97 0.8× 187 2.1× 83 1.0× 36 0.4× 18 770
Fei Huang China 11 177 0.6× 138 1.1× 86 1.0× 40 0.5× 37 0.4× 38 490
Tao-Yeuan Wang Taiwan 17 252 0.9× 102 0.8× 95 1.1× 40 0.5× 65 0.8× 23 676
Sumit Kar United States 10 261 0.9× 77 0.6× 49 0.6× 68 0.8× 50 0.6× 18 601
Yiwen Li China 14 413 1.4× 136 1.1× 67 0.8× 158 1.9× 128 1.5× 48 839
Norito Yagihashi Japan 14 246 0.9× 111 0.9× 136 1.5× 154 1.8× 43 0.5× 21 678
Birgül Özkesici Kurt Germany 14 226 0.8× 63 0.5× 41 0.5× 137 1.6× 45 0.5× 31 545
Ya Huang China 12 173 0.6× 150 1.2× 77 0.9× 99 1.2× 34 0.4× 23 525

Countries citing papers authored by Xiaoyang Lai

Since Specialization
Citations

This map shows the geographic impact of Xiaoyang Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Lai more than expected).

Fields of papers citing papers by Xiaoyang Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyang Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Lai. The network helps show where Xiaoyang Lai may publish in the future.

Co-authorship network of co-authors of Xiaoyang Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Lai. A scholar is included among the top collaborators of Xiaoyang Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Lai. Xiaoyang Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Huan, et al.. (2024). Unveiling cell subpopulations in T1D mouse islets using single-cell RNA sequencing. American Journal of Physiology-Endocrinology and Metabolism. 326(5). E723–E734. 1 indexed citations
2.
3.
Lai, Xiaoyang, et al.. (2024). Clinical features of early-onset type 2 diabetes and its association with triglyceride glucose-body mass index: a cross-sectional study. Frontiers in Endocrinology. 15. 1356942–1356942. 7 indexed citations
4.
Jiao, Xiaojuan, et al.. (2023). Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction. The Journal of Clinical Endocrinology & Metabolism. 108(11). 2916–2923. 11 indexed citations
5.
Lai, Xiaoyang, et al.. (2023). Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China. Diabetes Metabolic Syndrome and Obesity. Volume 16. 2491–2502. 2 indexed citations
6.
Duan, Peng, Weihong Li, Lina Wang, et al.. (2022). The Correlation between Thyroid Hormone Levels and the Kidney Disease Progression Risk in Patients with Type 2 Diabetes. Diabetes Metabolic Syndrome and Obesity. Volume 15. 59–67. 16 indexed citations
7.
8.
Wang, Wei, et al.. (2021). Exosomes secreted by palmitic acid-treated hepatocytes promote LX-2 cell activation by transferring miRNA-107. Cell Death Discovery. 7(1). 174–174. 22 indexed citations
9.
Xue, Guohui, Fangfang Li, Xiaoyang Lai, et al.. (2020). Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease. Cytokine. 134. 155184–155184. 38 indexed citations
10.
Zhang, Jing, Xingming Shi, Liu Yang, et al.. (2020). Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Aging. 12(23). 24270–24287. 194 indexed citations
11.
12.
Yu, Peng, Xi Xu, Jing Zhang, et al.. (2019). Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway. International Journal of Endocrinology. 2019. 1–11. 15 indexed citations
13.
14.
Wu, Juan, et al.. (2018). Bilateral cataracts as the first manifestation of type 1 diabetes mellitus. Medicine. 97(42). e12874–e12874. 6 indexed citations
15.
Gu, Lijuan, et al.. (2017). Effects of Passive Smoking on Glycemic Parameters and Lipid Profiles in a Chinese Female Population. Clinical Laboratory. 63(07+08/2017). 1147–1152. 5 indexed citations
16.
Zou, Fang, et al.. (2017). Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.. PubMed. 9(11). 5127–5137. 13 indexed citations
17.
Lai, Xiaoyang, et al.. (2014). Meta-analysis of coronary artery bypass graft surgery combined with stem cell transplantation in the treatment of ischemic heart diseases. Coronary Artery Disease. 26(2). 170–175. 4 indexed citations
18.
Lai, Xiaoyang, et al.. (2012). Effect of four different anti-osteoporosis agents on the expression of matrix gla protein in primary osteoblasts of SD rat. Zhonghua neifenmi daixie zazhi. 28(12). 956–961. 1 indexed citations
19.
Chen, Xueying, et al.. (2012). [Effect of estrogen on the expression of matrix GLA protein in ovariectomized SD rats].. PubMed. 47(11). 833–8. 1 indexed citations
20.
Lai, Xiaoyang. (2007). Clinical Control Study on Photoimpact Acupoint Stimulation for Diabetic Neuropathy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weixia Jian Breakdown of academic impact, for papers by Can Wu Breakdown of academic impact, for papers by Lechu Yu Breakdown of academic impact, for papers by Fei Huang Breakdown of academic impact, for papers by Tao-Yeuan Wang Breakdown of academic impact, for papers by Sumit Kar Breakdown of academic impact, for papers by Yiwen Li Breakdown of academic impact, for papers by Norito Yagihashi Breakdown of academic impact, for papers by Birgül Özkesici Kurt Breakdown of academic impact, for papers by Ya Huang
Rankless by CCL
2026